Felbamate (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Felbamate drug offered from Mylan Pharmaceuticals Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | felbamate |
SUBSTANCE NAME: | FELBAMATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-01-12 |
END MARKETING DATE: | 2018-03-31 |
Felbamate HUMAN PRESCRIPTION DRUG Details:
Item Description | Felbamate from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2016-01-12 |
END MARKETING DATE: | 2018-03-31 |
PRODUCT ID: | 0378-4110_f05ebe8e-8143-406b-b28a-2acfb1cc029d |
PRODUCT NDC: | 0378-4110 |
APPLICATION NUMBER: | ANDA204595 |
Other FELBAMATE Pharmaceutical Manufacturers / Labelers: